Form 483

FARMAKEIO OUTSOURCING LLC Form 483, 2022-06-10

FDA issued a Form 483 to FARMAKEIO OUTSOURCING LLC on 2022-06-10 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

FARMAKEIO OUTSOURCING LLC · Southlake, United States · Issued June 10, 2022

Overview

  • 6 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

10 Jun 2022
21 CFR 211.100(a)

Approval and review of procedures

Cited by Patty P Kaewussdangkul, Steven A Brettler

10 Jun 2022
21 CFR 211.137(a)

Expiration date lacking

Cited by Patty P Kaewussdangkul, Steven A Brettler

10 Jun 2022
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Patty P Kaewussdangkul, Steven A Brettler

10 Jun 2022
21 CFR 211.165(a)

Testing and release for distribution

Cited by Patty P Kaewussdangkul, Steven A Brettler

10 Jun 2022
FDCA 503B(a)(10)

Container label, outsourcer facility

Cited by Patty P Kaewussdangkul, Steven A Brettler

Inspected site

FOFARMAKEIO OUTSOURCING LLCSouthlake, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
FDCA 503B(a)(10)Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.137(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere